This titrate-up and taper-down controversy stems from concerns regarding the potential for hyperglycemia upon initiation of total parenteral nutrition (TPN) and for hypoglycemia upon discontinuation.

ENGLEWOOD, Colo., April 7 /PRNewswire/ -- Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release ...

Sept. 12, 2003 — Hypermanganesemia related to total parenteral nutrition (TPN) is common and may be problematic in patients awaiting intestinal transplant, according to a presentation at the VIII ...